Efficacy and safety of pyrotinib‐containing regimen in the patients with HER2‐positive metastatic breast cancer: A multicenter real‐world study
2022 · Cancer Medicine · 17 citations
https://doi.org/10.1002/cam4.5056
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
0
Papers
0
Citations
Weiwei Yi is an academic researcher.
https://doi.org/10.1002/cam4.5056
https://doi.org/10.1016/j.plantsci.2024.111974
Click to start Chat